Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
A policy framework for leveraging generative AI to address enduring challenges in clinical trials
5
Zitationen
5
Autoren
2025
Jahr
Abstract
Can artificial intelligence improve clinical trial design? Despite their importance in medicine, over 40% of trials involve flawed protocols. We introduce and propose the development of application-specific language models (ASLMs) for clinical trial design across three phases: ASLM development by regulatory agencies, customization by Health Technology Assessment bodies, and deployment to stakeholders. This strategy could enhance trial efficiency, inclusivity, and safety, leading to more representative, cost-effective clinical trials.
Ähnliche Arbeiten
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
2003 · 10.822 Zit.
Estimating the mean and variance from the median, range, and the size of a sample
2005 · 9.010 Zit.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 · 6.983 Zit.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
2020 · 5.337 Zit.
The global landscape of AI ethics guidelines
2019 · 4.663 Zit.